We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.45%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,452.87%
AUM
$3.43B
AUM Growth
+$187M
(+5.8%)
Cap. Flow
-$93.9M
Cap. Flow
% of AUM
-2.74%
Top 10 Holdings %
Top 10 Hldgs %
15.47%
Holding
218
New
12
Increased
43
Reduced
121
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$14.8M |
| 2 |
Cognex
CGNX
|
+$12.2M |
| 3 |
Azenta
AZTA
|
+$11.9M |
| 4 |
XLRN
Acceleron Pharma
XLRN
|
+$10.7M |
| 5 |
ABCO
Advisory Board Co
ABCO
|
+$9.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$27.8M |
| 2 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$21.8M |
| 3 |
CoStar Group
CSGP
|
+$12.3M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$10.6M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.94% |
| 2 | Healthcare | 15.18% |
| 3 | Consumer Discretionary | 14.11% |
| 4 | Industrials | 12.3% |
| 5 | Communication Services | 4.67% |
Similar funds
HBT
BC
EMFAT
BMCM
SW
WFMPM
AG
TA
Granahan Investment Management's Q4 2014 Portfolio in Review
As of Q4 2014, Granahan Investment Management held 218 positions worth $3.43B, up 5.8% from $3.24B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Granahan Investment Management's Q4 2014 filing shows 12 new, 43 increased, 121 reduced and 7 closed positions. Its largest new stake was Azenta: 1,023,321 shares worth $13M. The largest sale was West Pharmaceutical, an estimated $27.8M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Granahan Investment Management's largest Q4 2014 buy was Azenta: 1,023,321 shares worth $13M.
- Granahan Investment Management added most to Axon Enterprise in Q4 2014, an estimated $14.8M increase.
- Granahan Investment Management's biggest Q4 2014 reduction was West Pharmaceutical, cutting an estimated $27.8M.
- Granahan Investment Management fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $21.8M.
- Granahan Investment Management's ten largest holdings make up 15% of its $3.43B portfolio in Q4 2014.
- Granahan Investment Management opened 12 new positions and closed 7 in Q4 2014.
- Granahan Investment Management's portfolio value rose 5.8% quarter-over-quarter to $3.43B.
Based on Granahan Investment Management's 13F filing for Q4 2014, filed 20 Jan 2015.